Neurocrine Bioscience buy Citigroup Inc.
Start price
07.04.26
/
50%
€112.90
Target price
07.04.27
€209.89
Performance (%)
15.72%
Price
21.08.26
€130.65
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ currently has a performance of 15.72%. This prediction currently runs until 07.04.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -1.023% | -1.023% |
| iShares Core DAX® | -1.283% | 4.209% |
| iShares Nasdaq 100 | -3.338% | -1.744% |
| iShares Nikkei 225® | -4.286% | -1.621% |
| iShares S&P 500 | -2.311% | -0.096% |
Comments by Citigroup_Inc_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Citigroup Inc. from $204.00 to $242.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€143.95
31.07.26
31.07.26
€216.33
31.07.27
31.07.27
-9.97%
21.08.26
21.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.15
06.05.26
06.05.26
€209.89
06.05.27
06.05.27
6.09%
21.08.26
21.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€103.35
12.02.26
12.02.26
€171.73
12.02.27
12.02.27
26.42%
21.08.26
21.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.75
29.10.25
29.10.25
€174.28
29.10.26
29.10.26
10.96%
21.08.26
21.08.26